A Speedinvest portfolio company

Rivia

Sector
Health & Bio
Year Invested
2024
AI-driven analytics and data infrastructure for successful Biopharma clinical trials.

Rivia addresses inefficiencies in biopharma clinical trials, where fragmented data and outdated tools hinder the development of new therapies. Their technology offers a real-time, integrated view of data to improve the evaluation of new treatments and trial conduct. Their vision is to become the unified data infrastructure that transforms clinical development lifecycles, bringing new therapies to market more successfully.

Switzerland
Share
Links
LinkedIn
Related Companies
hi.health

Convenient and safe access to private health insurance billing.

Sector
Health & Bio
Exits
AI & Infra
Year Invested
2019
IOMED

Better ICD-10 coding and big data insights for hospitals.

Sector
Health & Bio
AI & Infra
Year Invested
2018
Juli

Improving life for people with chronic conditions.

Sector
Health & Bio
Year Invested
2022
MiLaboratories

The leader in immunome data analysis software with flagship product MiXCR.

Sector
Deep Tech
Health & Bio
Year Invested
2022
Molecule

Connecting life science research to funding.

Sector
Health & Bio
Year Invested
2022
Mpiriq

MPIRIQ links everyday clinical data with medical research to turn routine patient care into insights that accelerate new therapies.

Sector
Health & Bio
Year Invested
2024
NeuroHarmonics

Building the future of non-invasive neuromodulation using focused ultrasound to modulate deep brain circuits safely.

Sector
Health & Bio
Year Invested
2025
Nilo Health

The mental well-being support for your entire workforce.

Sector
Health & Bio
Marketplaces & Consumer
Year Invested
2022